1. Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: development and validation of a new methodology;Giorgi;Journal of Pharmaceutical and Biomedical Analysis,2012
2. Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain;Sánchez del Águila;Clinical Therapeutics,2015
3. Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and pregabalin for the management of severe, chronic low back pain with a neuropathic component: a randomized, double-blind, Phase 3b study;Baron;Pain Practice,2015